Filter
834
Featured
84
51
Language
Document type
193
191
166
73
69
39
29
28
12
8
7
5
4
2
Countries / Regions
37
24
22
16
15
8
8
7
7
7
6
5
5
4
4
4
4
4
4
3
3
3
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Authors & Publishers
Publication Years
Category
135
32
12
9
6
5
3
Key facts. Available in English, French, Russian and Spanish
Questions and answers. A key priority is preventing the interruption of current HIV treatment and prevention medicines. This Q&A outlines advice when this is not possible. Available in Arabic, Chinese, English, French, Portuguese, Russian and Spanish
IAS–USA Topics in Antiviral Medicine. September 22, 2025
By 2030, without accelerated scale-up of prevention and treatment coverage there may be an estimated 320 000 new HIV infections and 7.6 million people living with HIV
Tuberculosis (TB) remains a serious public health threat in South Africa and is the
leading cause of death in people living with HIV (PWH). Pre-hospital and early in-
hospital mortality is of particular concern in PWH. Significant progress has been made
to date, but a monumental effort is require
...
Poster presented CROI 2025
Topics in Antiviral Medicine, volume 33 Issue 2 May 2025
This issue brief provides information about TB and HIV clinical trials and research programs
impacted by U.S. government funding disruptions, and proposes urgent actions that
donor agencies, governments, and philanthropies can take to preserve scientific advances
underway and prevent the collapse
...
These 2025 guidelines respond to the need for better approaches to identify advanced HIV disease, improve the poor outcomes of people living with HIV being discharged from hospital and provide updated guidance for treatment for Kaposi’s sarcoma through evidence-informed recommendations. The public
...
Pan African Medical Journal. 2025;51:65.
BHIVA guidelines on antiretroviral treatment for adults living with HIV-1 2022 (2025 interim update)
The purpose of the 2025 interim update of the guidelines was to update our recommendations based on new evidence since the last update, including: (i) incorporating new evidence related to injectable therapy including frequency of viral load monitoring and use of long-acting cabotegravir/rilpivirine
...
Core Guidance. Differentiated service delivery is highlighted as a key approach for HIV programmes to enhance implementation quality and efficiency.
A toolkit for health facilities. This toolkit highlights successful differentiated-care approaches implemented in a number of settings and countries in sub-Saharan Africa. The toolkit will be further updated as more experience is gained with these and similar
approaches
This is the 2025 draft Malawi Guidelines for Syndromic Management of Sexually Transmitted Infections which is yet to be approved by the SMT.
Although strides have been made in the HIV response, children are still affected by the epidemic
Progress in reducing new HIV infections among children has stagnated in recent years
About nine per cent of all orphans globally have lost one or both parents due to an AIDS-related cause
In order to ramp up our efforts in the fight against AIDS, there is a need for more concentrated focus on adolescents and young people
About six in ten adolescents 10-19 years of age living with HIV are on antiretroviral medications
Slightly more than half of children under 15 years of age living with HIV are on antiretroviral medications
